Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Afrigen Biologics (Pty) Ltd logo — Afrigen Biologics and Vaccines

Afrigen Biologics (Pty) Ltd

Afrigen Biologics and Vaccines

Founded 2014 South Africa South Africa 109 employees

General Information

Company Name Afrigen Biologics (Pty) Ltd
Founded Year 2014
Location South Africa South Africa +1
Employees 109
Social

Get notified when Afrigen Biologics (Pty) Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Afrigen Biologics (Pty) Ltd

Afrigen Biologics and Vaccines is a Cape Town based biotechnology company strategically directed, supported and capitalized by Avacare Healthcare Group and the Industrial Development Corporation (IDC) of South Africa. It was founded in 2014 by Steven G. Reed (PhD) and Erik Iverson (JD, LLM), both of the Infectious Diseases Research Institute (IDRI) in Seattle. Afrigen drives a business strategy focussing on product development, bulk adjuvant manufacturing, and supply and distribution of key biologicals to address unmet healthcare needs. Through international partnerships and local capacity building, Afrigen has established the first ever adjuvant production and formulation technology centre on the African continent. This centre, in partnership with IDRI, a world leader in adjuvant development, focuses on next generation vaccine adjuvants, which are not only geared at preventing disease, but have therapeutic value. These adjuvants confer added potency and durability to vaccines. MISSION Afrigen is dedicated to the local development and production of adjuvants for human and animal vaccines, as well as biologicals critical for Africa’s healthcare challenges. PLEASE VIEW OUR PRIVACY STATEMENT & DISCLAIMERS HERE: https://www.afrigen.co.za/privacy-statement/ https://www.afrigen.co.za/disclaimers/

No funding data available for Afrigen Biologics (Pty) Ltd yet.

Get notified when Afrigen Biologics (Pty) Ltd raises funding

Afrigen Biologics (Pty) Ltd Alternatives & Competitors

Afrigen Biologics (Pty) Ltd vs
Mubea
Mubea Germany

Mubea is the family run lightweight construction specialist for high-strength automotive components....

4422 employees
Manufacturing
Afrigen Biologics (Pty) Ltd vs
ulrich medical
ulrich medical Germany

dedicated to you.

396 employees
Afrigen Biologics (Pty) Ltd vs
ZDF Studios
ZDF Studios Germany

inspire - create - produce - distribute

140 employees
Entertainment

FAQ About Afrigen Biologics (Pty) Ltd

Afrigen Biologics and Vaccines
Afrigen Biologics (Pty) Ltd was founded in 2014.
Afrigen Biologics (Pty) Ltd is headquartered in South Africa.
Afrigen Biologics (Pty) Ltd has approximately 109 employees.
Top alternatives and competitors to Afrigen Biologics (Pty) Ltd include Mubea, ulrich medical, ZDF Studios, HEDRICH Group, Biovaccines Nigeria Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Afrigen Biologics (Pty) Ltd and Mubea are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Afrigen Biologics (Pty) Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes